The effect of sulpiride on amphetamine-induced disruption of overshadowing in the rat

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 28, Issue 8, 2004, Pages 1249-1253

  O'Tuathaigh, Colm P ^a   Moran, Paula M ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

d amphetamine; Dopamine; Overshadowing; Schizophrenia; Stimulus selection; Sulpiride

Indexed keywords

AMPHETAMINE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; SULPIRIDE;

ANIMAL MODEL; ARTICLE; AVERSION; CONDITIONING; CONTROLLED STUDY; DRUG EFFECT; DRUG SELECTIVITY; LEARNING; MALE; NONHUMAN; RAT; STIMULUS RESPONSE; TASK PERFORMANCE;

AMPHETAMINE; ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; CONDITIONING, CLASSICAL; DISCRIMINATION LEARNING; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; INHIBITION (PSYCHOLOGY); MALE; RATS; RATS, SPRAGUE-DAWLEY; SULPIRIDE;

EID: 9944258051     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2004.06.009     Document Type: Article

References (28)

1. C.V. Buhusi, and N. Schmajuk Attention, configuration, and hippocampal function Hippocampus 6 6 1996 621 642
2. G. Cassens, A.K. Inglis, P.S. Appelbaum, and T.G. Gutheil Neuroleptics: effects on neuropsychological function in chronic schizophrenic patients Schizophr. Bull. 16 3 1990 477 499
3. B. Cornblatt, M. Obuchowski, S. Roberts, S. Pollack, and L. Erlenmeyer-Kimling Cognitive and behavioural precursors of schizophrenia Dev. Psychopathol. 11 1999 487 508
4. A. Crider, P.R. Solomon, and M.A. McMahon Disruption of selective attention in the rat following d-amphetamine administration: relationship to schizophrenic attentional disorder Biol. Psychiatry 17 1982 351 361
5. J. Feldon, and I. Weiner The latent inhibition model of schizophrenic and attention disorder. Haloperidol and sulpiride enhance rats' ability to ignore irrelevant stimuli Biol. Psychiatry 29 1991 635 646
6. N.S. Gray, L.S. Pilowsky, J.A. Gray, and R.W. Kerwin Latent inhibition in drug naïve schizophrenics: relationship to duration of illness and dopamine D2 binding using SPECT Schizophr. Res. 17 1995 95 107
7. M.F. Green What are the functional consequences of neurocognitive deficits in schizophrenia ? Am. J. Psychiatry 153 1996 321 330
8. G.R. Hancock, and A.J. Klockars The quest for alpha: Developments in multiple comparison procedures in the quarter century since Games (1971) Rev. Educ. Res. 66 3 1996 269 306
9. A.A. Harrison, B.J. Everitt, and T.W. Robbins Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergic mechanisms Psychopharmacology 133 4 1997 329 342
10. M.H. Joseph, S.L. Peters, P.M. Moran, G.A. Grigoryan, A.M. Young, and J.A. Gray Modulation of latent inhibition in the rat by altered dopamine transmission in the nucleus accumbens at the time of conditioning Neuroscience 101 4 2000 921 930
11. C.D. Kilts The changing roles and targets for animal models of schizophrenia Biol. Psychiatry 50 11 2001 845 855
12. S. Kapur, R. Zipursky, C. Jones, G. Remington, and S. Houle Relationship between dopamine D2 occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia Am. J. Psychiatry 157 4 2000 514 520
13. N.J. Mackintosh A theory of attention: variations in the associability of stimuli with reinforcement Psychol. Rev. 82 1975 276 298
14. M.A. Mehta, B.J. Sahakian, P.J. McKenna, and T.W. Robbins Systemic sulpiride in young adult volunteers simulates the profile of cognitive deficits in Parkinson's disease Psychopharmacology 146 2 1999 162 174
15. P.M. Moran, T.R. Fischer, J.M. Hitchcock, and P.C. Moser Effects of clozapine on latent inhibition in the rat Behav. Pharmacol. 7 1996 42 48
16. P.C. Moser, J.M. Hitchcock, S. Lister, and P.M. Moran The pharmacology of latent inhibition as an animal model of schizophrenia Brain Res.-Brain Res. Rev. 33 2-3 2000 275 307
17. A. Nieoullon Dopamine and the regulation of cognition and attention Prog. Neurobiol. 67 1 2002 53 83
18. R.D. Oades, M.L. Rao, S. Bender, G. Sartory, and B.W. Muller Neuropsychological and conditioned blocking performance in patients with schizophrenia: assessment of the contribution of neuroleptic dose, serum levels, and dopamine d2-receptor occupancy Behav. Pharmacol. 11 3-4 2000 317 330
19. R.D. Oades, A. Klimke, U. Henning, and M.L. Rao Relations of clinical features, subgroups and medication to serum monoamines in schizophrenia Hum. Psychopharmacol. 17 1 2002 15 27
20. D. Ohad, R.E. Lubow, I. Weiner, and J. Feldon The effects of amphetamine on blocking Psychobiology 15 2 1987 137 143
21. C.M. O'Tuathaigh, and P.M. Moran Evidence for dopamine D(1) receptor involvement in the stimulus selection task: overshadowing in the rat Psychopharmacology 162 3 2002 225 231
22. C.M. O'Tuathaigh, C. Salum, A.M. Young, A.D. Pickering, M.H. Joseph, and P.M. Moran The effect of amphetamine on Kamin blocking and overshadowing Behav. Pharmacol. 14 4 2003 315 322
23. F. Passetti, J.W. Dalley, and T.W. Robbins Double dissociation of serotonergic and dopaminergic mechanisms on attentional performance using a rodent five-choice reaction time task Psychopharmacology 165 2 2003 136 145
24. T.W. Robbins The case of frontostriatal dysfunction in schizophrenia Schizophr. Bull. 16 3 1990 391 402
25. M.V. Seeman The "marriage bed": brain and outcome in schizophrenia Can. J. Psychiatry 42 1 1997 19 20
26. L.J. Seidman, K.J. Van Manen, W.M. Turner, D.M. Gamser, S.V. Faraone, J.M. Goldstein, and M.T. Tsuang The effects of increasing resource demand on vigilance performance in adults with schizophrenia or developmental attentional/learning disorders: a preliminary study Schizophr. Res. 34 1998 101 112
27. B.G. Soares, M. Fenton, and P. Chue Sulpiride for schizophrenia Cochrane Database Syst. Rev. 2 2000 (CD001162)
28. I. Weiner The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment Psychopharmacology 169 3-4 2003 257 297